<VariationArchive VariationID="424754" VariationName="NM_015506.2(MMACHC):c.[271dupA];[482G&gt;A]" VariationType="CompoundHeterozygote" Accession="VCV000424754" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2016-01-01" MostRecentSubmission="2016-01-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Genotype VariationID="424754">
      <SimpleAllele AlleleID="16460" VariationID="1421">
        <GeneList>
          <Gene Symbol="MMACHC" FullName="metabolism of cobalamin associated C" GeneID="25974" HGNC_ID="HGNC:24525" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>1p34.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45500300" stop="45513382" display_start="45500300" display_stop="45513382" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45965855" stop="45976738" display_start="45965855" display_stop="45976738" Strand="+" />
            </Location>
            <OMIM>609831</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_015506.3(MMACHC):c.271dup (p.Arg91fs)</Name>
        <CanonicalSPDI>NC_000001.11:45507544:A:AA</CanonicalSPDI>
        <VariantType>Duplication</VariantType>
        <Location>
          <CytogeneticLocation>1p34.1</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45507544" stop="45507545" display_start="45507544" display_stop="45507545" variantLength="1" positionVCF="45507544" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45973216" stop="45973217" display_start="45973216" display_stop="45973217" variantLength="1" positionVCF="45973216" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        </Location>
        <ProteinChange>R91fs</ProteinChange>
        <ProteinChange>R34fs</ProteinChange>
        <HGVSlist>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45973217dup" Assembly="GRCh37">
              <Expression>NC_000001.10:g.45973217dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45507545dup" Assembly="GRCh38">
              <Expression>NC_000001.11:g.45507545dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_013378.1" sequenceAccession="NG_013378" sequenceVersion="1" change="g.12362dup">
              <Expression>NG_013378.1:g.12362dup</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001330540.2" sequenceAccession="NM_001330540" sequenceVersion="2" change="c.100dup">
              <Expression>NM_001330540.2:c.100dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001317469.1" sequenceAccession="NP_001317469" sequenceVersion="1" change="p.Arg34fs">
              <Expression>NP_001317469.1:p.Arg34fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015506.3" sequenceAccession="NM_015506" sequenceVersion="3" change="c.271dup" MANESelect="true">
              <Expression>NM_015506.3:c.271dup</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_056321.2" sequenceAccession="NP_056321" sequenceVersion="2" change="p.Arg91fs">
              <Expression>NP_056321.2:p.Arg91fs</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015506.3" sequenceAccession="NM_015506" sequenceVersion="3" change="c.271dupA" MANESelect="true">
              <Expression>NM_015506.3:c.271dupA</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015506.3" sequenceAccession="NM_015506" sequenceVersion="3" change="c.270_271insA" MANESelect="true">
              <Expression>NM_015506.3:c.270_271insA</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-04-04" DateCreated="2011-01-25" MostRecentSubmission="2024-07-10" NumberOfSubmissions="47" NumberOfSubmitters="45">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">16311595</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">16714133</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17768669</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17853453</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">18164228</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">18245139</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19370762</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19760748</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20549364</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20610126</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20631720</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23837176</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">24126030</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">24599607</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25687216</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25894566</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28835862</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">29294253</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">29302025</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">31137025</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">31279840</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">32164588</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">33562640</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">36338977</ID>
            </Citation>
            <Citation Type="review" Abbrev="GeneReviews">
              <ID Source="PubMed">20301503</ID>
              <ID Source="BookShelf">NBK1328</ID>
            </Citation>
            <DescriptionHistory Dated="2024-02-17">
              <Description>Conflicting classifications of pathogenicity</Description>
            </DescriptionHistory>
            <DescriptionHistory Dated="2019-06-17">
              <Description>Pathogenic</Description>
            </DescriptionHistory>
            <ConditionList>
              <TraitSet ID="91572" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="70846" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">MMACHC-related disorder</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MMACHC-related condition</ElementValue>
                  </Name>
                </Trait>
              </TraitSet>
              <TraitSet ID="32973" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="36303" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic aciduria with homocystinuria cblC type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Methylmalonic acidemia with homocystinuria cblC</ElementValue>
                  </Name>
                  <XRef ID="CN239025" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="7947" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="9459" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Atypical hemolytic-uremic syndrome</ElementValue>
                    <XRef ID="MONDO:0016244" DB="MONDO" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Atypical HUS</ElementValue>
                  </Name>
                  <Symbol>
                    <ElementValue Type="Alternate">D-HUS</ElementValue>
                  </Symbol>
                  <Symbol>
                    <ElementValue Type="Alternate">AHUS</ElementValue>
                    <XRef ID="GTR000515140" DB="Genetic Testing Registry (GTR)" />
                  </Symbol>
                  <AttributeSet>
                    <Attribute Type="public definition">Hemolytic-uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs. The onset of atypical HUS (aHUS) ranges from the neonatal period to adulthood. Genetic aHUS accounts for an estimated 60% of all aHUS. Individuals with genetic aHUS frequently experience relapse even after complete recovery following the presenting episode; 60% of genetic aHUS progresses to end-stage renal disease (ESRD).</Attribute>
                    <XRef ID="NBK1367" DB="GeneReviews" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="8702" />
                    <XRef ID="8702" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301541</ID>
                    <ID Source="BookShelf">NBK1367</ID>
                  </Citation>
                  <Citation Type="review" Abbrev="NEJM, 2009">
                    <ID Source="PubMed">19846853</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="Brit Cmt Stand Hematol/BTS, 2010">
                    <ID Source="PubMed">19821824</ID>
                  </Citation>
                  <XRef ID="2134" DB="Orphanet" />
                  <XRef ID="C2931788" DB="MedGen" />
                  <XRef ID="MONDO:0016244" DB="MONDO" />
                </Trait>
              </TraitSet>
              <TraitSet ID="384" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="5516" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic aciduria and homocystinuria, Vitamin B12-responsive</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Vitamin B12 metabolic defect with combined deficiency of methylmalonyl-CoA mutase and homocysteine:methyltetrahydrofolate methyltransferase</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Cobalamin C disease</ElementValue>
                    <XRef ID="74653006" DB="SNOMED CT" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">methylmalonic aciduria and homocystinuria type cblC</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Cobalamin-C methylmalonic acidemia and homocystinuria</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic acidemia and homocystinuria cblC type</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="12128" />
                    <XRef ID="12128" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                    <XRef ID="NBK1328" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301503</ID>
                    <ID Source="BookShelf">NBK1328</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                    <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                    <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
                  </Citation>
                  <XRef ID="26" DB="Orphanet" />
                  <XRef ID="79282" DB="Orphanet" />
                  <XRef ID="C1848561" DB="MedGen" />
                  <XRef ID="MONDO:0010184" DB="MONDO" />
                  <XRef Type="MIM" ID="277400" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="16994" Type="PhenotypeInstruction" ContributesToAggregateClassification="true">
                <Trait ID="18728" Type="PhenotypeInstruction">
                  <Name>
                    <ElementValue Type="Preferred">See cases</ElementValue>
                  </Name>
                </Trait>
              </TraitSet>
              <TraitSet ID="13518" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="9483" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Disorders of Intracellular Cobalamin Metabolism</ElementValue>
                    <XRef ID="296703" DB="GeneTests" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                    <XRef ID="NBK1328" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301503</ID>
                    <ID Source="BookShelf">NBK1328</ID>
                  </Citation>
                  <XRef ID="CN043592" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="40617" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="38585" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC</ElementValue>
                    <XRef Type="Allelic variant" ID="176763.0001" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="176763.0002" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="609831.0012" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="609831.0011" DB="OMIM" />
                    <XRef Type="Allelic variant" ID="609831.0013" DB="OMIM" />
                    <XRef ID="277400" DB="OMIM" />
                  </Name>
                  <XRef ID="C4693974" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="16789" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not specified</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
                  </AttributeSet>
                  <XRef ID="CN169374" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="32761" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
                  </Name>
                  <Citation Type="general" Abbrev="Langer et al., 2012">
                    <ID Source="PubMed">22947299</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="SACHDNC, 2013">
                    <ID Source="PubMed">23037933</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                    <ID Source="PubMed">23169492</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                    <ID Source="PubMed">25626707</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                    <ID Source="PubMed">24121147</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="NBSTRN, 2015">
                    <ID Source="PubMed">24394680</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="EUNENBS, 2014">
                    <ID Source="PubMed">23652378</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="NSGC, 2014">
                    <ID Source="PubMed">23881473</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                    <ID Source="PubMed">25730230</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="Skirton et al., 2014">
                    <ID Source="PubMed">24022298</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACMG, 2013">
                    <ID Source="PubMed">23619275</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACOG, 2019">
                    <ID Source="PubMed">31022120</ID>
                  </Citation>
                  <XRef ID="C0950123" DB="MedGen" />
                  <XRef ID="D030342" DB="MeSH" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA090937" DB="ClinGen" />
          <XRef Type="Allelic variant" ID="609831.0001" DB="OMIM" />
          <XRef Type="Allelic variant" ID="609831.0011" DB="OMIM" />
          <XRef Type="rs" ID="398124292" DB="dbSNP" />
          <XRef Type="Interpreted" ID="424754" DB="ClinVar" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00078" Source="1000 Genomes Project 30x" />
          <AlleleFrequency Value="0.00093" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00100" Source="1000 Genomes Project" />
          <AlleleFrequency Value="0.00110" Source="Exome Aggregation Consortium (ExAC)" />
          <AlleleFrequency Value="0.00111" Source="Trans-Omics for Precision Medicine (TOPMed)" />
          <AlleleFrequency Value="0.00116" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
          <AlleleFrequency Value="0.00116" Source="The Genome Aggregation Database (gnomAD), exomes" />
        </AlleleFrequencyList>
        <GlobalMinorAlleleFrequency Value="0.00100" Source="1000 Genomes Project" MinorAllele="AA" />
      </SimpleAllele>
      <SimpleAllele AlleleID="16464" VariationID="1425">
        <GeneList>
          <Gene Symbol="MMACHC" FullName="metabolism of cobalamin associated C" GeneID="25974" HGNC_ID="HGNC:24525" Source="submitted" RelationshipType="within single gene">
            <Location>
              <CytogeneticLocation>1p34.1</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45500300" stop="45513382" display_start="45500300" display_stop="45513382" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45965855" stop="45976738" display_start="45965855" display_stop="45976738" Strand="+" />
            </Location>
            <OMIM>609831</OMIM>
          </Gene>
        </GeneList>
        <Name>NM_015506.3(MMACHC):c.482G&gt;A (p.Arg161Gln)</Name>
        <CanonicalSPDI>NC_000001.11:45508847:G:A</CanonicalSPDI>
        <VariantType>single nucleotide variant</VariantType>
        <Location>
          <CytogeneticLocation>1p34.1</CytogeneticLocation>
          <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45508848" stop="45508848" display_start="45508848" display_stop="45508848" variantLength="1" positionVCF="45508848" referenceAlleleVCF="G" alternateAlleleVCF="A" />
          <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45974520" stop="45974520" display_start="45974520" display_stop="45974520" variantLength="1" positionVCF="45974520" referenceAlleleVCF="G" alternateAlleleVCF="A" />
        </Location>
        <ProteinChange>R161Q</ProteinChange>
        <ProteinChange>R104Q</ProteinChange>
        <HGVSlist>
          <HGVS Type="protein">
            <ProteinExpression sequenceAccessionVersion="Q9Y4U1" sequenceAccession="Q9Y4U1" change="p.Arg161Gln">
              <Expression>Q9Y4U1:p.Arg161Gln</Expression>
            </ProteinExpression>
          </HGVS>
          <HGVS Assembly="GRCh37" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45974520G&gt;A" Assembly="GRCh37">
              <Expression>NC_000001.10:g.45974520G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Assembly="GRCh38" Type="genomic, top-level">
            <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45508848G&gt;A" Assembly="GRCh38">
              <Expression>NC_000001.11:g.45508848G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_013378.1" sequenceAccession="NG_013378" sequenceVersion="1" change="g.13665G&gt;A">
              <Expression>NG_013378.1:g.13665G&gt;A</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_001330540.2" sequenceAccession="NM_001330540" sequenceVersion="2" change="c.311G&gt;A">
              <Expression>NM_001330540.2:c.311G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_001317469.1" sequenceAccession="NP_001317469" sequenceVersion="1" change="p.Arg104Gln">
              <Expression>NP_001317469.1:p.Arg104Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
          <HGVS Type="coding">
            <NucleotideExpression sequenceAccessionVersion="NM_015506.3" sequenceAccession="NM_015506" sequenceVersion="3" change="c.482G&gt;A" MANESelect="true">
              <Expression>NM_015506.3:c.482G&gt;A</Expression>
            </NucleotideExpression>
            <ProteinExpression sequenceAccessionVersion="NP_056321.2" sequenceAccession="NP_056321" sequenceVersion="2" change="p.Arg161Gln">
              <Expression>NP_056321.2:p.Arg161Gln</Expression>
            </ProteinExpression>
            <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO" />
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification DateLastEvaluated="2024-03-29" DateCreated="2011-01-25" MostRecentSubmission="2024-06-13" NumberOfSubmissions="18" NumberOfSubmitters="18">
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description>Pathogenic</Description>
            <Citation Type="general">
              <ID Source="PubMed">11320193</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">16311595</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">16714133</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">17853453</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">18164228</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19370762</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">19700356</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20219402</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">20631720</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">21055272</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">22560872</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">23825108</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25687216</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">25809485</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28218226</ID>
            </Citation>
            <Citation Type="general">
              <ID Source="PubMed">28693988</ID>
            </Citation>
            <Citation Type="general">
              <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MMACHC</URL>
            </Citation>
            <Citation Type="review" Abbrev="GeneReviews">
              <ID Source="PubMed">20301503</ID>
              <ID Source="BookShelf">NBK1328</ID>
            </Citation>
            <ConditionList>
              <TraitSet ID="91572" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="70846" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">MMACHC-related disorder</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">MMACHC-related condition</ElementValue>
                  </Name>
                </Trait>
              </TraitSet>
              <TraitSet ID="32973" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="36303" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic aciduria with homocystinuria cblC type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Methylmalonic acidemia with homocystinuria cblC</ElementValue>
                  </Name>
                  <XRef ID="CN239025" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="32761" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
                  </Name>
                  <Citation Type="general" Abbrev="Langer et al., 2012">
                    <ID Source="PubMed">22947299</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="SACHDNC, 2013">
                    <ID Source="PubMed">23037933</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                    <ID Source="PubMed">23169492</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                    <ID Source="PubMed">25626707</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                    <ID Source="PubMed">24121147</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="NBSTRN, 2015">
                    <ID Source="PubMed">24394680</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="EUNENBS, 2014">
                    <ID Source="PubMed">23652378</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="NSGC, 2014">
                    <ID Source="PubMed">23881473</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                    <ID Source="PubMed">25730230</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="Skirton et al., 2014">
                    <ID Source="PubMed">24022298</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACMG, 2013">
                    <ID Source="PubMed">23619275</ID>
                  </Citation>
                  <Citation Type="general" Abbrev="ACOG, 2019">
                    <ID Source="PubMed">31022120</ID>
                  </Citation>
                  <XRef ID="C0950123" DB="MedGen" />
                  <XRef ID="D030342" DB="MeSH" />
                </Trait>
              </TraitSet>
              <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="17556" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">none provided</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">not provided</ElementValue>
                    <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
                  </AttributeSet>
                  <XRef ID="C3661900" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="384" Type="Disease" ContributesToAggregateClassification="true">
                <Trait ID="5516" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic aciduria and homocystinuria, Vitamin B12-responsive</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Vitamin B12 metabolic defect with combined deficiency of methylmalonyl-CoA mutase and homocysteine:methyltetrahydrofolate methyltransferase</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Cobalamin C disease</ElementValue>
                    <XRef ID="74653006" DB="SNOMED CT" />
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">methylmalonic aciduria and homocystinuria type cblC</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Cobalamin-C methylmalonic acidemia and homocystinuria</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic acidemia and homocystinuria cblC type</ElementValue>
                  </Name>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="12128" />
                    <XRef ID="12128" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                    <XRef ID="NBK1328" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301503</ID>
                    <ID Source="BookShelf">NBK1328</ID>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                    <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
                  </Citation>
                  <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                    <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                    <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
                  </Citation>
                  <XRef ID="26" DB="Orphanet" />
                  <XRef ID="79282" DB="Orphanet" />
                  <XRef ID="C1848561" DB="MedGen" />
                  <XRef ID="MONDO:0010184" DB="MONDO" />
                  <XRef Type="MIM" ID="277400" DB="OMIM" />
                </Trait>
              </TraitSet>
              <TraitSet ID="13518" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="9483" Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Disorders of Intracellular Cobalamin Metabolism</ElementValue>
                    <XRef ID="296703" DB="GeneTests" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                    <XRef ID="NBK1328" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301503</ID>
                    <ID Source="BookShelf">NBK1328</ID>
                  </Citation>
                  <XRef ID="CN043592" DB="MedGen" />
                </Trait>
              </TraitSet>
              <TraitSet ID="6471" Type="Disease" ContributesToAggregateClassification="false">
                <Trait ID="5517" Type="Disease">
                  <Name>
                    <ElementValue Type="Alternate">Methylmalonic aciduria, mut type</ElementValue>
                  </Name>
                  <Name>
                    <ElementValue Type="Preferred">Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency</ElementValue>
                    <XRef ID="Methylmalonyl-Coenzyme+A+mutase+deficiency/4721" DB="Genetic Alliance" />
                    <XRef ID="MONDO:0009612" DB="MONDO" />
                  </Name>
                  <AttributeSet>
                    <Attribute Type="GARD id" integerValue="3586" />
                    <XRef ID="3586" DB="Office of Rare Diseases" />
                  </AttributeSet>
                  <AttributeSet>
                    <Attribute Type="public definition">For this GeneReview, the term "isolated methylmalonic acidemia" refers to a group of inborn errors of metabolism associated with elevated methylmalonic acid (MMA) concentration in the blood and urine that result from the failure to isomerize (convert) methylmalonyl-coenzyme A (CoA) into succinyl-CoA during propionyl-CoA metabolism in the mitochondrial matrix, without hyperhomocysteinemia or homocystinuria, hypomethioninemia, or variations in other metabolites, such as malonic acid. Isolated MMA is caused by complete or partial deficiency of the enzyme methylmalonyl-CoA mutase (mut0 enzymatic subtype or mut– enzymatic subtype, respectively), a defect in the transport or synthesis of its cofactor, 5-deoxy-adenosyl-cobalamin (cblA, cblB, or cblD-MMA), or deficiency of the enzyme methylmalonyl-CoA epimerase. Prior to the advent of newborn screening, common phenotypes included: Infantile/non-B12-responsive form (mut0 enzymatic subtype, cblB), the most common phenotype, associated with infantile-onset lethargy, tachypnea, hypothermia, vomiting, and dehydration on initiation of protein-containing feeds. Without appropriate treatment, the infantile/non-B12-responsive phenotype could rapidly progress to coma due to hyperammonemic encephalopathy. Partially deficient or B12-responsive phenotypes (mut– enzymatic subtype, cblA, cblB [rare], cblD-MMA), in which symptoms occur in the first few months or years of life and are characterized by feeding problems, failure to thrive, hypotonia, and developmental delay marked by episodes of metabolic decompensation. Methylmalonyl-CoA epimerase deficiency, in which findings range from complete absence of symptoms to severe metabolic acidosis. Affected individuals can also develop ataxia, dysarthria, hypotonia, mild spastic paraparesis, and seizures. In those individuals diagnosed by newborn screening and treated from an early age, there appears to be decreased early mortality, less severe symptoms at diagnosis, favorable short-term neurodevelopmental outcome, and lower incidence of movement disorders and irreversible cerebral damage. However, secondary complications may still occur and can include intellectual disability, tubulointerstitial nephritis with progressive impairment of renal function, "metabolic stroke" (bilateral lacunar infarction of the basal ganglia during acute metabolic decompensation), pancreatitis, growth failure, functional immune impairment, bone marrow failure, optic nerve atrophy, arrhythmias and/or cardiomyopathy (dilated or hypertrophic), liver steatosis/fibrosis/cancer, and renal cancer.</Attribute>
                    <XRef ID="NBK1231" DB="GeneReviews" />
                  </AttributeSet>
                  <Citation Type="review" Abbrev="GeneReviews">
                    <ID Source="PubMed">20301409</ID>
                    <ID Source="BookShelf">NBK1231</ID>
                  </Citation>
                  <XRef ID="27" DB="Orphanet" />
                  <XRef ID="C1855114" DB="MedGen" />
                  <XRef ID="MONDO:0009612" DB="MONDO" />
                  <XRef Type="MIM" ID="251000" DB="OMIM" />
                </Trait>
              </TraitSet>
            </ConditionList>
          </GermlineClassification>
        </Classifications>
        <XRefList>
          <XRef ID="CA223191" DB="ClinGen" />
          <XRef ID="Q9Y4U1#VAR_024779" DB="UniProtKB" />
          <XRef Type="Allelic variant" ID="609831.0005" DB="OMIM" />
          <XRef Type="rs" ID="121918243" DB="dbSNP" />
          <XRef Type="Interpreted" ID="424754" DB="ClinVar" />
        </XRefList>
        <AlleleFrequencyList>
          <AlleleFrequency Value="0.00007" Source="The Genome Aggregation Database (gnomAD)" />
          <AlleleFrequency Value="0.00014" Source="Trans-Omics for Precision Medicine (TOPMed)" />
          <AlleleFrequency Value="0.00015" Source="Exome Aggregation Consortium (ExAC)" />
          <AlleleFrequency Value="0.00017" Source="The Genome Aggregation Database (gnomAD), exomes" />
        </AlleleFrequencyList>
      </SimpleAllele>
      <Name>NM_015506.2(MMACHC):c.[271dupA];[482G&gt;A]</Name>
      <VariationType>CompoundHeterozygote</VariationType>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression>
            <Expression>NM_015506.2:c.[271dupA];[482G&gt;A]</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </Genotype>
    <RCVList>
      <RCVAccession Title="NM_015506.2(MMACHC):c.[271dupA];[482G&gt;A] AND multiple conditions" Accession="RCV000203236" Version="11">
        <ClassifiedConditionList TraitSetID="23571">
          <ClassifiedCondition DB="MedGen" ID="C5561925">Benign concentric annular macular dystrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848561">Cobalamin C disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-10-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-10-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-01-01" MostRecentSubmission="2016-01-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25687216</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="23571" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2718" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Macular dystrophy, concentric annular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Benign concentric annular macular dystrophy</ElementValue>
                <XRef ID="MONDO:0007934" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BCAMD</ElementValue>
                <XRef Type="MIM" ID="153870" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCDCA</ElementValue>
                <XRef Type="MIM" ID="153870" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9887" />
                <XRef ID="9887" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="251287" DB="Orphanet" />
              <XRef ID="C5561925" DB="MedGen" />
              <XRef ID="MONDO:0007934" DB="MONDO" />
              <XRef Type="MIM" ID="153870" DB="OMIM" />
            </Trait>
            <Trait ID="5516" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cobalamin-C methylmalonic acidemia and homocystinuria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic acidemia and homocystinuria cblC type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Methylmalonic aciduria and homocystinuria, Vitamin B12-responsive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vitamin B12 metabolic defect with combined deficiency of methylmalonyl-CoA mutase and homocysteine:methyltetrahydrofolate methyltransferase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cobalamin C disease</ElementValue>
                <XRef ID="74653006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">methylmalonic aciduria and homocystinuria type cblC</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range: In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction. Newborns, who can have microcephaly, poor feeding, and encephalopathy. Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS). Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures. Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, and/or subacute combined degeneration of the spinal cord.</Attribute>
                <XRef ID="NBK1328" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12128" />
                <XRef ID="12128" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301503</ID>
                <ID Source="BookShelf">NBK1328</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="26" DB="Orphanet" />
              <XRef ID="79282" DB="Orphanet" />
              <XRef ID="C1848561" DB="MedGen" />
              <XRef ID="MONDO:0010184" DB="MONDO" />
              <XRef Type="MIM" ID="277400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="482971" SubmissionDate="2015-11-04" DateLastUpdated="2016-01-01" DateCreated="2016-01-01">
        <ClinVarSubmissionID localKey="NM_015506.2:c.[482G&gt;A];[271dupA]|MedGen:C1848561;C1828210" />
        <ClinVarAccession Accession="SCV000256726" DateUpdated="2016-01-01" DateCreated="2016-01-01" Type="SCV" Version="2" SubmitterName="Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine" OrgID="505572" OrganizationCategory="laboratory" OrgAbbreviation="BHCMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-10-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25687216</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Collison et al. (Opthalmic Genet. 2015)</Attribute>
          <Citation>
            <ID Source="PubMed">25687216</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>Hispanic</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
              <FamilyData NumFamiliesWithSegregationObserved="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <Citation>
                <ID Source="PubMed">23806086</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">24088041</ID>
              </Citation>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <Genotype>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="MMACHC" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_015506.2:c.482G&gt;A</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_015506.2:c.482G&gt;A</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <SimpleAllele>
            <GeneList>
              <Gene Symbol="MMACHC" />
            </GeneList>
            <VariantType>Variation</VariantType>
            <AttributeSet>
              <Attribute Type="HGVS">NM_015506.2:c.271dupA</Attribute>
            </AttributeSet>
            <AttributeSet>
              <Attribute Type="HGVS">NM_015506.2:c.271dupA</Attribute>
            </AttributeSet>
          </SimpleAllele>
          <VariationType>CompoundHeterozygote</VariationType>
        </Genotype>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848561" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1828210" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">25687216</ID>
        </Citation>
        <Comment>Patient presented at 28 years with decreased central vision</Comment>
        <SubmissionNameList>
          <SubmissionName>Collison_Opth_Genet_2014_MMACHC</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="482971" TraitType="Disease" MappingType="XRef" MappingValue="C1828210" MappingRef="MedGen">
        <MedGen CUI="C1828210" Name="Bull's eye maculopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="482971" TraitType="Disease" MappingType="XRef" MappingValue="C1848561" MappingRef="MedGen">
        <MedGen CUI="C1848561" Name="Cobalamin C disease" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

